Matthew Kutny, MD

Dr. Kutny’s clinical practice focuses on treatment of children with leukemia, lymphoma and histiocytic disorders. His clinical research focuses on improving treatments for pediatric leukemia. He holds several national leadership roles through the Children’s Oncology Group (COG): the National Cancer Institute’s pediatric cancer cooperative group. Dr. Kutny is an appointed member of the myeloid disease steering committee, and he leads development of international clinical trials for pediatric acute myeloid leukemia.